Circumcision in subject with hemophilia: the Yogyakarta Method.

Background Circumcision is one of the most common surgical procedures in boys in Indonesia. In cases patient with hemophilia (PWH), doctors tend to avoid this procedure due to increased bleeding tendency. In 2007, we developed a protocol for clotting factor concentrate (CFC) administration for circu...

Descripción completa

Detalles Bibliográficos
Publicado en:Paediatrica Indonesiana Vol. 64; no. 3; pp. 244 - 250
Autores principales: Widjajanto, Pudjo Hagung, Wibowo, Agus, Saputro, Ivan Onggo, Budiono, Nur, Hadi, Nurul, Tusino, Agus, Sutowo, David Wijaya
Formato: clinical trial pictorial protocol research tables/charts Journal Article
Publicado: Indonesian Pediatric Society May2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178328869&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178328869
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00309311
        LPSA
      jtl: Paediatrica Indonesiana
      issn: 00309311
      maglogo: N
    pubinfo:
      dt: May2024
      vid: 64
      iid: 3
      pid: 50274
      pub: Indonesian Pediatric Society
    artinfo:
      ui:
        178328869
        178328869
        178328869
        10.14238/pi64.3.2024.244-9
        178328869
      ppf: 244
      ppct: 6
      formats:
      tig:
        atl: Circumcision in subject with hemophilia: the Yogyakarta Method.
      aug:
        au:
          Widjajanto, Pudjo Hagung
          Wibowo, Agus
          Saputro, Ivan Onggo
          Budiono, Nur
          Hadi, Nurul
          Tusino, Agus
          Sutowo, David Wijaya
        affil: Division of Pediatric Hematology & Oncology, Dr. Sardjito Hospital/Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada
      sug:
        subj:
          Hemophilia Complications
          Hemorrhage Drug Therapy
          Circumcision Adverse Effects
          Hemostasis, Surgical Methods
          Blood Coagulation Factors Therapeutic Use
          Blood Coagulation Factors Administration and Dosage
          Treatment Outcomes
          Human
          Male
          Child, Preschool
          Child
          Adolescence
          Young Adult
          Descriptive Research
          Medical Records
          Record Review
          Indonesia
          Hospitalization
          Preoperative Care
          Wound Healing
          Age Factors
          Severity of Illness Indices
          Hemophilia Classification
          Tranexamic Acid Administration and Dosage
          Blood Loss, Surgical Prevention and Control
          Clinical Trials
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Adolescent: 13-18 years
          Male
      ab: Background Circumcision is one of the most common surgical procedures in boys in Indonesia. In cases patient with hemophilia (PWH), doctors tend to avoid this procedure due to increased bleeding tendency. In 2007, we developed a protocol for clotting factor concentrate (CFC) administration for circumcision in PWH, namely, the "Yogyakarta Method." Objective To evaluate the outcomes of the Yogyakarta Method for circumcising PWH. Methods This descriptive study was based on medical records of PWH who underwent circumcision at Dr. Sardjito Hospital (DSH), Yogyakarta and 3 surrounding hospitals under DSH supervision from 2008-2017 and 2018-2022. Diagnoses of hemophilia were based on clinical findings and factor assays. Subjects with hemophilia A received factor VIII (25 IU/kg/dose) and those with hemophilia B received factor IX (50 IU/kg/dose) before, during and after the procedure. In addition, patients received tranexamic acid (15 mg/kg/dose). Circumcision was performed by a pediatric surgeon or urologist. Results From 2008-2017, 28 PWH underwent circumcision, 14/28 of whom were in DSH. Twenty-six patients had hemophilia A and 2 had hemophilia B. Their severities were mild (12 subjects), moderate (10 subjects), and severe (6 subjects). Subjects' median age was 10.5 (5-19) years and their median CFC use was 8 (range 7-10) doses in hemophilia A and 4 (range 4-5) doses in hemophilia B patients. Three of 28 PWH had bleeding episodes after the procedure. Following the encouraging results from the initial 2008-2017 study period, most of PWH circumcised in 2018-2022 underwent the procedure in the same 3 district hospitals rather than at DSH (21/28 subjects), and had similar CFC consumption. Only 1 bleeding episode occurred after the procedure during the second study period. Conclusion The Yogyakarta method is safe and sufficient to control bleeding in circumcision of PWH. This method is also suitable in a district hospital setting.
      pubtype: Academic Journal
      doctype:
        clinical trial
        pictorial
        protocol
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N